The Cancer Vaccine Institute is proud to recognize Stephanie N. today! Stephanie was diagnosed with HER2-positive breast cancer in 2000 and participated in a CVI vaccine clinical trial in 2011. What’s remarkable about Stephanie is her commitment to supporting and advocating for others who have been diagnosed with cancer. She often accompanied CVI clinical trial participants who had come in from out of state to their appointments, even doing airport pick-ups.
In 2003, Stephanie became involved with HER2support.org, an organization that advocates for people diagnosed with HER2 positive cancers. As the new therapies were being tested in trials, she wanted to connect with and follow others on her path hoping for eventual wellness. She wondered, is there a Silver Bullet? Stephanie believes research has uncovered a few Silver Bullets and many more patients like her with dire diagnoses are living full and meaningful lives.
Stephanie is now participating in metastatic breast cancer studies with the Metastatic Breast Cancer Project and the Network of Enigmatic Exceptional Responders. She also serves on the CVI’s Patient Advisory Council to advise us on patient education and engagement initiatives, and work with us in our endeavor for research with the patient always in focus. Thank you, Stephanie, for everything you do to support patients and CVI research!